David Colleran - EVP, General Counsel, Corp Sec at Anika Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, General Counsel, Corp Sec
Stock Symbol
ANIK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Colleran since 12/23/2023

Holdings reported by David Colleran for Anika Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 33K $851K $25.79 Mar 11, 2024 Direct
Restricted Stock Unit 19.3K $499K $25.79 Mar 15, 2024 Direct Common Stock
Stock Option (Right to Buy) 46.9K Mar 15, 2024 Direct Common Stock

Transactions reported by David Colleran for Anika Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.